Events and webinars

Date: 23 October 2024

Time: 9am - 5.00pm (exact timings TBC)

Location: The Royal College of Psychiatrists, London

Applicable rate: £275 per delegate

What will this masterclass explore?

This masterclass will be delivered by clinicians working in the Na tional Specialist Adolescent Mood disorders Service (SAMS) and Complex Neurodevelopmental Disorders Service (CNDS) at Newcastle. The programme will cover diagnostic criteria and epidemiology of bipolar disorder (BD), comorbid conditions, before moving on to consider approaches to assessment and management of BD. Delegates will have the opportunity to present clinical scenarios from their caseload throughout the day.

What will you learn from this masterclass?

• Update on DSM-5 and ICD-11 diagnostic criteria for BD
• Framework for assessment of BD
• Management approaches for BD
• Differential diagnoses and/or comorbid conditions such as ASD, ADHD, Personality Disorder

Speaker information

Dr Adi Sharmais a Clinical Senior Lecturer and Hon Consultant in child and adolescent psychiatry at Translational and Clinical Research Institute, Newcastle University and Cumbria, Northumberland Tyne and Wear NHS Foundation Trust. His clinical academic interests include the mood disorders, psychopharmacology and digital interventions in children and young people. He is clinical lead for the Specialist Adolescent Mood disorders Service (SAMS) based at Newcastle which provides a second opinion for children and young people under 18 with mood disorders.

Dr Eleanor Smithis a Consultant Child and Adolescent Psychiatrist with Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust and an Associate Clinical Lecturer at Newcastle University. She is the Consultant Psychiatrist and Acting Clinical Lead for the Complex Neurodevelopmental Disorders Service (CNDS), a specialist second opinion tertiary regional Autism Spectrum Disorder Clinical Academic Team. She is a qualified Autism Diagnostic Observation Schedule (ADOS-2) and Autism Diagnostic Interview-Revised (ADI-R) trainer. She provides autism expertise into the SAMS team.

Ms Clare Oxberry is an Advanced Occupational Therapist with Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust working into both the SAMS and CNDS teams. She has completed an MA in Psychoanalytical Observation studies. In addition to her discipline specific expertise, she utilises her psychodynamic and non-directive play therapy skills in considering the complex presentations seen by both teams.

Dr Emma Honey is Consultant Clinical Psychologist with Cumbria Northumberland Tyne and Wear NHS Foundation Trust working into the SAMS Team. She has a PhD from Durham University and the Doctorate in Clinical Psychology from Newcastle University. She has considerable expertise in psychological formulations and adapting psychological interventions according to the developmental needs of clients particularly so in the context of ASD and ID.

(L-R) Dr Adi Sharma, Dr Eleanor Smith, Ms Clare Oxberry, Dr Emma Honey

Make a payment to access this recording

Originally held on: 17 February 2022
Duration: 45 minutes approx

What does this webinar explore?

In March 2020, TEC Cymru was asked to support the coronavirus response by implementing a national programme of remote consultations.

CWTCH (Connecting with Telehealth to Communities and Hospitals), a Health Foundation-funded project in CAMHS, was used as an exemplar to roll out remote consultations across Wales.

A data-driven approach was taken, and the findings are challenging - this is because patients, carers and families were asked what they thought too.

Using a phased approach, TEC Cymru have mixed methods data from more than 50,000 patients and clinicians using the service. Data will be shared in this webinar which challenges current accepted beliefs about health inequality and digital exclusion, describes user experience and expectations, and highlights some of the challenges and opportunities of using digital innovations in delivering health and social care.

What can you expect to learn from this webinar?

In particular, this webinar will focus on:

• Learning from the national rollout and implementation of technology-enabled care during COVID-19.
• Evaluation, including benefits, challenges, and emerging evidence (from a mental and physical health perspective).
• Digital inclusion.
• Embedding learning and moving forward.

Information on our guest presenter, Professor Alka Ahuja MBE

Professor Alka Ahuja MBE is a Consultant Child and Adolescent Psychiatrist at Aneurin Bevan University Health Board.

Alka is the National Clinical Lead for the Welsh Government Technology Enabled Care Programme. She is also the vice-chair of the Child and Adolescent Faculty of the Royal College of Psychiatrists and the Public Education lead, Royal College of Psychiatrists in Wales.

Alka is also a Visiting Professor at the University of South Wales, and an Honorary Professor at Cardiff University. Her expertise is in qualitative research methodology and her areas of special interest include neurodevelopmental disorders, including autism and ADHD, service user and carer involvement in healthcare services, and employment of digital technology in healthcare.

Make a payment to access this recording

Originally held on: 15 December 2021
Duration: 1 hour approx.

What does this webinar explore?

ADHD was previously seen as a childhood developmental disorder, which meant that adult mental health services have not been set up to support ADHD patients who become too old for child services. This webinar will present the results of the first in-depth study of the transition of ADHD patients from child to adult health services in the UK.

This webinar will explore:

• how many young people (of which ADHD) are in need of services as an adult what services are available for young adults with ADHD
• how ADHD stakeholders experience transition from child to adult services

What can you expect to learn from this webinar?

By the end of this webinar, delegates will:

• have evidence to estimate the likely number of young adults in their population who will need transition
• understand the availability of services for young adults with ADHD and how to access them
• gain increased  awareness of the impact of untreated ADHD at this crucial life-stage and the need for continued treatment for those that need it
• understand the likely points for drop out from treatment and how the experience of transition could be improved to prevent loss of service

Information on our guest presenter, Dr Tamsin Ford

Tamsin Ford CBE is a Professor of Child and Adolescent Psychiatry at the University of Cambridge, which she joined in October 2019. Her academic work focuses on the effectiveness of interventions and the efficiency of services in relation to the mental health of children and young people, with a particular focus on the interface between the education and health systems. She has been involved in all three national surveys of child and adolescent mental health, has run and supported several large trials of school-based interventions and is an epidemiologist by academic background. She completed her PhD at the Institute of Psychiatry, Kings College London and moved to Exeter where she set up and led the Child Mental Health Research Group between 2007 and 2019.

Make a payment to access this recording

Presented by Dr Tamsin Newlove-Delagado

Originally held on: 29 June 2022
Duration: 60 minutes approx.

What does this webinar explore?

This webinar focusses on children and young people’s (CYP) mental health at a population level, and will summarise the evolving evidence available on the impact of Covid-19. Whilst the Covid-19 pandemic appears to have moved into a different phase in the UK, there is much to be done to understand and address the mental health impacts, and the unintended consequences of our public health response for children and young people.

Governments and other agencies must also plan for future pandemics, balancing risks, harms and benefits, and the differential impacts across society. Such decision making must be informed by the best possible evidence from research and practice, and our learning from Covid-19.

What will be learned from this webinar?

Drawing on the latest data from the Mental Health of Children and Young People in England surveys and other high-quality sources, the webinar will discuss the following questions:

• What do we know about the impact on children and young people’s mental health on a population level?
• What are the implications for future trends, and how might this impact on services?
• How can we be better prepared in future to support CYP mental health in the case of a pandemic?

Information on our guest presenter, Dr. Tamsin Newlove-Delgado

Tamsin Newlove-Delgado is a Senior Clinical Lecturer with the Children and Young People’s Mental Health Research Collaboration (ChYMe) at the University of Exeter, and an Honorary Consultant in Public Health Medicine with the Office for Health Improvement and Disparities (OHID, formerly Public Health England).

She has been a member of  NHS Digital’s Mental Health of Children and Young People in England survey consortium throughout the pandemic, providing academic input to the 2020, 2021 and 2022 surveys, and was lead author on the MHCYP 2021 survey report.

Influenced by her clinical experience in child and adolescent psychiatry prior to entering public health, Tamsin's research concentrates on public health aspects of the mental health of children and young people. She is currently funded by an NIHR Advanced Fellowship, which aims to study time trends in child and adolescent mental health and mental health related service contacts.

Make a payment to access this recording

Originally held on: 25 November 2022
Duration: 1 hour approx.

What does this webinar explore?

FASD is an increasingly recognised condition which represents the most common single aetiological cause of neurodevelopmental presentations, which is also preventable. With rates of between 2-4% of the UK population suggested to have FASD, in some groups such as those in care, the rates have been suggested to be as high as 27%.

Whilst many recognise the full dysmorphic profile of FASD, this is relatively uncommon with often less than 5 % of those diagnosed meeting full criteria on the facial criteria. Updated diagnostic profiling from the Scottish SIGN guidance, adopted in England, and NICE Quality Standards published in March 22, are driving the need for better recognition and change. FASD is therefore now a condition that in increasingly presenting and demand for recognition by families is growing, yet many professionals still find themselves with only limited knowledge about FASD.

FASD presents with a complex neurodevelopmental profile and overlays complex trauma issues that lead to behavioural challenges to many areas including CAMHS, ID, Forensic and General Adult psychiatric services. The lack of recognition often leads to impropriate service utilisation, therefore better recognition and understanding will help to appropriately deliver treatment and support to this vulnerable group. There are increasingly specific treatment pathways developing for this group that increases the importance of recognition and support.

What can you expect to learn from this webinar?

The Webinar will offer brief insights to the following areas:

• What is FASD and the different risk of alcohol prenatally at different levels to an individual
• Prevalence in the UK and in some other at risk populations
• FASD in the context of a complex trauma model
• Where FASD fits into a wider Neurodevelopmental world
• Developing treatment and intervention approaches specific to FASD

Information on our guest presenter, Professor Raja Mukherjee

Professor Raja Mukherjee is an Adult Learning Disability Consultant Psychiatrist for Surrey and Border’s Partnership NHS Foundation Trust, with interest in the management of developmental disorders across the lifespan. In September 2009 he started the first NHS based specialist Fetal Alcohol Spectrum Disorders behavioural clinic and since then has seen over 250 cases for specialist second opinion as a National referral service. Dr Mukherjee completed his PhD on the subject of Fetal Alcohol Syndrome in 2014.

He has also acted as an invited advisor to the BMA board of science, The Department of Health and the World Health Organisation on the subject of FASD. In 2015 Dr Mukherjee also gave evidence to the first All Party Parliamentary Group on FASD at the House of commons. He has continues to support national clinical developments related to FASD. Dr Mukherjee is a member of the NICE quality standards group for FASD. He is currently the only UK representative to a US, NIH sponsored initiative to consider the research criteria for FASD. In his own time he volunteers as a medical advisor to various FASD charities both in the UK and internationally. In 2021 he was made an Honorary Professor at the University of Salford related to his work on FASD.

In wider work, he is currently Clinical Lead for Adult neurodevelopmental services provided by Surrey and Borders including Adult ASD and ADHD services across Surrey, Hampshire and Portsmouth. He is a an executive committee member of the RCPsych SIG on neurodevelopmental disorders, and Finance officer from July 2021. He is also a member of the ID Faculty Executive.